{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"23.22","value":"93.26"},{"groupId":"OG001","spread":"22.37","value":"89.48"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"25"},{"groupId":"OG001","value":"24"}],"units":"Participants"}],"title":"Day -3"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"22.43","value":"92.81"},{"groupId":"OG001","spread":"20.67","value":"87.24"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"24"},{"groupId":"OG001","value":"23"}],"units":"Participants"}],"title":"Day 8"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"24.11","value":"93.34"},{"groupId":"OG001","spread":"20.58","value":"89.44"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"25"},{"groupId":"OG001","value":"24"}],"units":"Participants"}],"title":"Day 14 or day of discharge, whichever is sooner"}],"denoms":[{"counts":[{"groupId":"OG000","value":"25"},{"groupId":"OG001","value":"24"}],"units":"Participants"}],"description":"Patient standing weight in kilograms was taken at specific time points to assess any changes in nutritional status.","dispersionType":"Standard Deviation","groups":[{"description":"Patients will receive six doses of Uproleselan intravenously. The doses will begin the evening of Day -3 and continue every 12 hours through the morning of Day 0, prior to hematopoietic stem cell transplant (auto-HCT). On the evening of Day -2, patients also receive one dose of standard of care Melphalan intravenously.","id":"OG000","title":"Uproleselan + Standard of Care Melphalan"},{"description":"Patients will receive six doses of placebo intravenously. The doses will begin the evening of Day -3 and continue every 12 hours through the morning of Day 0, prior to hematopoietic stem cell transplant (auto-HCT). On the evening of Day -2, patients also receive one dose of standard of care Melphalan intravenously.","id":"OG001","title":"Placebo + Standard of Care Melphalan"}],"paramType":"MEAN","populationDescription":"The number of participants analyzed at each time point may differ from the overall number of participants analyzed because the data was not collected. One patient in the placebo + standard of care melphalan arm was not evaluable for the outcome measure.","reportingStatus":"POSTED","timeFrame":"Day -3, Day 8, and date of discharge or Day 14 (whichever is sooner) (up to be 18 days)","title":"Change in Nutritional Status as Assessed by Change in Standing Weight","type":"SECONDARY","unitOfMeasure":"kilograms"}